The Annual General Meeting of Precise Biometrics AB took place on Wednesday, May 22, 2024 in Lund, Sweden. The following main decisions were made.

Adoption of the income statement and the balance sheet etc.
The Annual General Meeting resolved to adopt the income statement and balance sheet for the parent company and the group for the previous financial year. The Board of Directors and the CEO were discharged from liability for the same period.

Allocation of the company’s result
The Annual General Meeting resolved, in accordance with the Board's proposal, that no dividend shall be paid for the financial year 2022 and that the Company’s result shall be carried forward.

Board of Directors
The Annual General Meeting resolved that the Board shall comprise five members. Torgny Hellström, Åsa Schwarz, Maria Rydén and Peter Gullander were re-elected as Board members, and Howard Ro was elected as new Board member. Torgny Hellström was re-elected as Chairman of the Board.

Remuneration for members of the Board of Directors
The Annual General Meeting resolved that Board remuneration shall be paid in the amount of SEK 545,000 to the Chairman of the Board and SEK 190,000 to each of the other member. The remuneration for committee work shall amount to SEK 90,000 to the chairman of the audit committee, SEK 45,000 to a member of the audit committee, and SEK 25,000 to member and chairman, respectively, of the remuneration committee. All remunerations are unchanged.

Auditor
Ernst & Young Aktiebolag was re-elected as auditor for the period until the end of the next Annual General Meeting. Authorised Public Accountant Martin Henriksson will be the auditor in charge. Fees to the auditor shall be paid in accordance with approved invoices.

Approval of the remuneration report
The Annual General Meeting resolved to approve the Board’s remuneration report.

Guidelines for remuneration to senior executives
The Annual General Meeting resolved, in accordance with the Board’s proposal, on guidelines for remuneration to senior executives. The guidelines entail no material changes compared to the previously applicable guidelines, adopted by the Annual General Meeting 2020.

Authorisation to resolve on issue of ordinary shares and/or convertible instruments
The Annual General Meeting resolved, in accordance with the Board’s proposal, on authorisation for the Board to, with or without deviation from the shareholders’ pre-emption rights, and on one or several occasions for the period up to the next Annual General Meeting, resolve to issue ordinary shares and/or convertible instruments regarding such shares corresponding to an increase of the Company’s share capital with not more than 20 percent of the share capital as per the date of the resolution on the new issue with the support of this authorisation.